# Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

> **NCT04245865** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Vejle Hospital** · enrollment: 83 (actual)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **DRUG:** Fluorouracil
- **DRUG:** Calcium folinate
- **DRUG:** Oxaliplatin
- **DRUG:** Bevacizumab
- **DRUG:** Capecitabine
- **DIETARY_SUPPLEMENT:** Tocotrienol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04245865
- **Lead sponsor:** Vejle Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-06-26
- **Primary completion:** 2025-03-31
- **Final completion:** 2026-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04245865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04245865, "Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04245865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*